Published in Medical Letter on the CDC and FDA, November 14th, 2004
Flumazenil Injection is the AP-rated generic equivalent for HLR Technology's Romazicon Injection, a product used to reverse the sedative effects of benzodiazepines.
The brand product has annual sales of approximately $48 million.
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 25 pharmaceutical companies and among the largest generic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.